Offering biomedical innovators the experience, expertise, and funding required for success.
Through the RCT Ventures program, venture capital is provided to start-up or early-stage companies with technologies that have the potential to become significant biomedical products with a definite competitive edge. Learn more ›
RCT develops and invests in technologies that enhance and enable the discovery and manufacture of therapeutics and diagnostics. Many of these life science tools are available from RCT through affordable nonexclusive licensing. Learn more ›
Evergreen capital base enables BroadOak to pursue its life sciences growth capital strategy over a longer horizon of investment cycles and to be opportunistic in special situations. BroadOak Capital Partners (“BroadOak”), a life science focused investment and advisory firm, announced … Learn more